BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36117362)

  • 1. [Progress in research of influenza vaccine and 23 valent pneumococcal polysaccharide vaccine immunization in patients with chronic obstructive pulmonary disease].
    Sui HT; Guo Y; Yang ZN; Su JF; Shu X; Zhang Y; Wang HQ; Yang X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Sep; 43(9):1508-1512. PubMed ID: 36117362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of influenza and pneumococcal vaccines on chronic obstructive pulmonary disease exacerbations.
    Li Y; Zhang P; An Z; Yue C; Wang Y; Liu Y; Yuan X; Ma Y; Li K; Yin Z; Wang L; Wang H
    Respirology; 2022 Oct; 27(10):844-853. PubMed ID: 35705329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of influenza and 23-valent pneumococcal polysaccharide vaccinations on elderly with chronic obstructive pulmonary diseases: a community-based intervention study].
    Wen Y; He L; Zhai Y; Wu J; Chen YY; Wang H; Zong QQ; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):792-798. PubMed ID: 29936749
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching.
    Song JY; Noh JY; Lee JS; Wie SH; Kim YK; Lee J; Jeong HW; Kim SW; Lee SH; Park KH; Choi WS; Cheong HJ; Kim WJ
    PLoS One; 2018; 13(12):e0207918. PubMed ID: 30521553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of vaccination with pneumococcal vaccines on recurrent pneumonia in patients with chronic obstructive pulmonary disease].
    Ignatova GL; Antonov VN
    Ter Arkh; 2022 Dec; 94(11):1257-1261. PubMed ID: 37167163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pneumococcal vaccine and influenza vaccine for prevention of exacerbation in patients with COPD].
    Matsuse H
    Nihon Rinsho; 2016 May; 74(5):839-42. PubMed ID: 27254956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic vaccinations in chronic obstructive pulmonary disease: current status.
    Varkey JB; Varkey AB; Varkey B
    Curr Opin Pulm Med; 2009 Mar; 15(2):90-9. PubMed ID: 19532022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Health economic evaluation of a 23 value pneumococcal polysaccharide vaccination pilot programme among elderly chronic obstructive pulmonary disease patients in China].
    Qiu YP; Zhao K; Li X; Shi LW; Guo WD; Qi XR; Sui BY; Zhou RM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1074-1078. PubMed ID: 28057111
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of the effectiveness and long-term results of formation of adaptive immunity in the use of various medications and vaccination schemes against pneumococcal infection in patients with chronic obstructive pulmonary disease].
    Protasov AD; Zhestkov AV; Kostinov MP; Shteiner ML; Tezikov YV; Lipatov IS; Yastrebova NE; Kostinova AM; Ryzhov AA; Polishchuk VB
    Ter Arkh; 2017; 89(12. Vyp. 2):165-174. PubMed ID: 29488477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are younger COPD patients adequately vaccinated for influenza and pneumococcus?
    Gogou E; Hatzoglou C; Zarogiannis SG; Siachpazidou D; Gerogianni I; Kotsiou OS; Varsamas C; Gourgoulianis KI
    Respir Med; 2022 Nov; 203():106988. PubMed ID: 36162248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.
    Domínguez A; Castilla J; Godoy P; Delgado-Rodríguez M; Saez M; Soldevila N; Astray J; Mayoral JM; Martín V; Quintana JM; González-Candelas F; Galán JC; Tamames S; Castro A; Baricot M; Garín O; Pumarola T;
    Hum Vaccin Immunother; 2013 Apr; 9(4):865-73. PubMed ID: 23563516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing acceptance of influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease.
    Saiphoklang N; Phadungwatthanachai J
    Hum Vaccin Immunother; 2022 Nov; 18(6):2102840. PubMed ID: 35943223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.
    Walters JA; Tang JN; Poole P; Wood-Baker R
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD001390. PubMed ID: 28116747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Which vaccines for COPD patients?].
    Burgel PR
    Rev Prat; 2024 Jan; 74(1):13-15. PubMed ID: 38329244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research progress of influenza vaccination, pneumococcal vaccination and COVID-19 vaccination among cancer patients].
    Sui HT; Guo Y; Yang ZN; Su JF; Shu X; Zhang Y; Yang XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jan; 57(1):100-106. PubMed ID: 36655265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers.
    Gilchrist SA; Nanni A; Levine O
    Am J Public Health; 2012 Apr; 102(4):596-605. PubMed ID: 22397339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza and pneumococcal vaccination coverage and associated factors in patients hospitalized with acute exacerbations of COPD in China: Findings from real-world data.
    He R; Ren X; Huang K; Lei J; Niu H; Li W; Dong F; Li B; Wang Y; Yang T; Wang C
    Chin Med J (Engl); 2024 May; 137(10):1179-1189. PubMed ID: 37488669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization.
    Song JY; Lee JS; Wie SH; Kim HY; Lee J; Seo YB; Jeong HW; Kim SW; Lee SH; Park KH; Noh JY; Choi WS; Cheong HJ; Kim WJ
    Clin Vaccine Immunol; 2015 Feb; 22(2):229-34. PubMed ID: 25540271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal vaccination and chronic respiratory diseases.
    Froes F; Roche N; Blasi F
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3457-3468. PubMed ID: 29255353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of starting 23-valent pneumococcal polysaccharide vaccine and influenza vaccination at 50 vs. 65 years: A comparative modelling study.
    Ding H; Huang J; Ngai CH; Sun Q; Kwok KO; Wang HH; Chong M; Wong MC
    Vaccine; 2022 Feb; 40(9):1282-1288. PubMed ID: 35094867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.